|This Slide: #8 of 100|
Slide #8. H. Lundbeck A/S (Lundbeck) — Chelsea Therapeutics International, Ltd.
H. Lundbeck A/S (Lundbeck)
Chelsea Therapeutics International, Ltd. (CHTP)
Chelsea Therapeutics International, Ltd. (Chelsea) (Nasdaq:CHTP), a biopharmaceutical development company, has entered into a definitive agreement to be acquired by H. Lundbeck A/S (Lundbeck) (LUN.CO) (LUN DC) (HLUYY), a global pharmaceutical company that specializes in brain diseases. The details of this transaction can be found in the joint press release issued by the two companies.
Free CHTP Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts
Hold (2.00 out of 4)
(ranked higher than approx. 100% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite